Compounds disclosed herein including compounds of formula I′:
and salts thereof are provided. Pharmaceutical compositions comprising compounds disclosed herein, processes for preparing compounds disclosed herein, intermediates useful for preparing compounds disclosed herein and therapeutic methods for treating an HIV infection using compounds disclosed herein are also provided.
BENZOTHIAZOLE COMPOUNDS AND THEIR PHARMACEUTICAL USE
申请人:Mitchell Michael L.
公开号:US20140045818A1
公开(公告)日:2014-02-13
The invention provides compounds of formula I: or a salt thereof as described herein. The invention also provides pharmaceutical compositions comprising a compound of formula I, processes for preparing compounds of formula I, intermediates useful for preparing compounds of formula I and therapeutic methods for treating the proliferation of the HIV virus, treating AIDS or delaying the onset of AIDS or ARC symptoms in a mammal using compounds of formula I.
Reactivity of 3,6-dimethoxy-3, 6-dimethylcyclohexa-1, 4-diene: nuclear versus benzylic nucleophilic substitution
作者:Francisco Alonso、Isidoro Barba、Miguel Yus
DOI:10.1016/s0040-4020(01)89773-8
日期:1990.1
ALONSO, FRANCISCO;BARBA, ISIDORO;YUS, MIGUEL, TETRAHEDRON, 46,(1990) N, C. 2069-2080
作者:ALONSO, FRANCISCO、BARBA, ISIDORO、YUS, MIGUEL
DOI:——
日期:——
Glycopeptide Antibiotic Monomer Derivatives
申请人:Arimoto Hirokazu
公开号:US20080097078A1
公开(公告)日:2008-04-24
Novel glycopeptide antibiotic derivatives. These derivatives are represented by the formula (aglycon part of glycopeptide antibiotic derivative)-(Sac-NH)—R
A
[wherein (aglycon part of glycopeptide antibiotic derivative) is the part formed by removing the sugar part from a known glycopeptide antibiotic derivative; (Sac-NH) part is an amino sugar part or a sugar chain part containing an amino sugar; and R
A
represents, e.g., the formula —X
1
—Ar
1
—X
2
—Y—X
3
—Ar
2
(wherein X
1
, X
2
, and X
3
each represents 1) a single bond or 2) a heteroatom or heteroatom-containing group selected from the group consisting of —N═, ═N—, —NR
1
—, —O—, etc.; Y represents —NR
2
CO— or —CONR
2
— (wherein R
2
represents hydrogen or lower alkyl), etc.)]. These derivatives have antibacterial activity against vancomycin-resistant bacteria.